Socioeconomic status affects cancer trial referrals

December 7, 2012
Socioeconomic status affects cancer trial referrals
Patients of lower socioeconomic status are less likely to be referred to participate in early-phase cancer trials compared with patients of higher socioeconomic status, according to research published online Dec. 3 in the Journal of Clinical Oncology.

(HealthDay)—Patients of lower socioeconomic status are less likely to be referred to participate in early-phase cancer trials compared with patients of higher socioeconomic status, according to research published online Dec. 3 in the Journal of Clinical Oncology.

Aisyah Mohd Noor, M.D., of King's College London, and colleagues used data from 10,784 incident cases to examine the effect of patient socioeconomic status on access to early-phase .

The researchers found that 430 patients were referred to an early-phase trials unit. Patients in the more-deprived quintiles were significantly less likely to be referred compared with patients in the less-deprived quintiles (odds ratio, 0.53). After review in the unit, trial enrollment was not affected by socioeconomic status. Non-white patients were significantly less likely to be recruited (odds ratio, 0.48), but after adjustment for age, gender, , and deprivation index, the association did not persist.

"The least-deprived patients are almost twice as likely to be referred compared with the most deprived," the authors write. "This may be because more-deprived patients are less suitable for a trial—as a result of comorbidities, for example—or because of inequalities that could be addressed by patient or referrer education. Once reviewed at the unit, enrollment onto a trial is not affected by deprivation."

Explore further: Poorest bowel cancer patients more likely to die within month of surgery

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Researchers thwart cancer cells by triggering 'virus alert'

August 27, 2015

Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.